Clinical Trial Update: Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ART-123 for safety and efficacy in sepsis with disseminated intravascular coagulation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disseminated Intravascular Coagulation
• Sepsis

Drugs mentioned

• ART-123 (recombinant human soluble thrombomodulin)

Snippet

Sponsor: Artisan Pharma, Inc. | Conditions: Sepsis, Disseminated Intravascular Coagulation | Phase 2 | Status: COMPLETED